nodes	percent_of_prediction	percent_of_DWPC	metapath
Primidone—CYP2C9—brain cancer	0.613	1	CbGaD
Primidone—CYP1A2—Carmustine—brain cancer	0.0506	0.309	CbGbCtD
Primidone—CYP3A4—Temozolomide—brain cancer	0.0382	0.234	CbGbCtD
Primidone—CYP3A4—Lomustine—brain cancer	0.0325	0.199	CbGbCtD
Primidone—CYP2C8—Etoposide—brain cancer	0.0194	0.118	CbGbCtD
Primidone—CYP1A2—Etoposide—brain cancer	0.015	0.0917	CbGbCtD
Primidone—GRIK2—cerebellar cortex—brain cancer	0.00799	0.0693	CbGeAlD
Primidone—CYP3A4—Etoposide—brain cancer	0.00786	0.048	CbGbCtD
Primidone—Anaemia megaloblastic—Hydroxyurea—brain cancer	0.00717	0.0875	CcSEcCtD
Primidone—CHRNA4—cochlea—brain cancer	0.00585	0.0508	CbGeAlD
Primidone—GRIK2—telencephalic ventricle—brain cancer	0.00465	0.0403	CbGeAlD
Primidone—CHRNA4—telencephalic ventricle—brain cancer	0.00373	0.0324	CbGeAlD
Primidone—GRIA2—ganglion—brain cancer	0.0032	0.0278	CbGeAlD
Primidone—Nystagmus—Procarbazine—brain cancer	0.00306	0.0373	CcSEcCtD
Primidone—Systemic lupus erythematosus—Hydroxyurea—brain cancer	0.00305	0.0372	CcSEcCtD
Primidone—GRIK2—ganglion—brain cancer	0.00289	0.0251	CbGeAlD
Primidone—Eruption—Hydroxyurea—brain cancer	0.00275	0.0335	CcSEcCtD
Primidone—Visual disturbance—Lomustine—brain cancer	0.00263	0.0321	CcSEcCtD
Primidone—GRIA2—hindbrain—brain cancer	0.00243	0.0211	CbGeAlD
Primidone—CHRNA7—ganglion—brain cancer	0.00236	0.0204	CbGeAlD
Primidone—Ataxia—Lomustine—brain cancer	0.00235	0.0286	CcSEcCtD
Primidone—GABRA6—hindbrain—brain cancer	0.00235	0.0204	CbGeAlD
Primidone—CHRNA4—ganglion—brain cancer	0.00232	0.0202	CbGeAlD
Primidone—GRIK2—hindbrain—brain cancer	0.00219	0.019	CbGeAlD
Primidone—GABRA2—ganglion—brain cancer	0.00208	0.0181	CbGeAlD
Primidone—Apathy—Temozolomide—brain cancer	0.00185	0.0226	CcSEcCtD
Primidone—Flat affect—Temozolomide—brain cancer	0.00183	0.0223	CcSEcCtD
Primidone—CHRNA4—hindbrain—brain cancer	0.00176	0.0153	CbGeAlD
Primidone—GABRB2—hindbrain—brain cancer	0.00173	0.015	CbGeAlD
Primidone—Visual impairment—Lomustine—brain cancer	0.00166	0.0203	CcSEcCtD
Primidone—Diplopia—Procarbazine—brain cancer	0.00158	0.0193	CcSEcCtD
Primidone—GABRA2—hindbrain—brain cancer	0.00158	0.0137	CbGeAlD
Primidone—GABRA1—hindbrain—brain cancer	0.00153	0.0132	CbGeAlD
Primidone—Ataxia—Procarbazine—brain cancer	0.00149	0.0182	CcSEcCtD
Primidone—GRIA2—brainstem—brain cancer	0.00139	0.0121	CbGeAlD
Primidone—GABRA6—brainstem—brain cancer	0.00134	0.0117	CbGeAlD
Primidone—GRIK2—brainstem—brain cancer	0.00126	0.0109	CbGeAlD
Primidone—GRIA2—telencephalon—brain cancer	0.00124	0.0107	CbGeAlD
Primidone—Drowsiness—Procarbazine—brain cancer	0.00122	0.0149	CcSEcCtD
Primidone—GABRA6—telencephalon—brain cancer	0.00119	0.0104	CbGeAlD
Primidone—Anorexia—Lomustine—brain cancer	0.00117	0.0143	CcSEcCtD
Primidone—GABRA5—telencephalon—brain cancer	0.00116	0.01	CbGeAlD
Primidone—CHRFAM7A—telencephalon—brain cancer	0.00113	0.00977	CbGeAlD
Primidone—GRIK2—telencephalon—brain cancer	0.00112	0.00968	CbGeAlD
Primidone—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.0011	0.0442	CbGpPWpGaD
Primidone—Decreased appetite—Lomustine—brain cancer	0.00107	0.013	CcSEcCtD
Primidone—GABRA4—telencephalon—brain cancer	0.00105	0.00911	CbGeAlD
Primidone—CHRNA4—brainstem—brain cancer	0.00101	0.00877	CbGeAlD
Primidone—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000993	0.0397	CbGpPWpGaD
Primidone—Diplopia—Carmustine—brain cancer	0.000991	0.0121	CcSEcCtD
Primidone—GABRB2—brainstem—brain cancer	0.00099	0.00859	CbGeAlD
Primidone—Diplopia—Temozolomide—brain cancer	0.000958	0.0117	CcSEcCtD
Primidone—Drowsiness—Hydroxyurea—brain cancer	0.000945	0.0115	CcSEcCtD
Primidone—Ataxia—Carmustine—brain cancer	0.000932	0.0114	CcSEcCtD
Primidone—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.000909	0.0364	CbGpPWpGaD
Primidone—CHRNA7—telencephalon—brain cancer	0.000909	0.00789	CbGeAlD
Primidone—GABRA2—brainstem—brain cancer	0.000904	0.00785	CbGeAlD
Primidone—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000904	0.0361	CbGpPWpGaD
Primidone—Ataxia—Temozolomide—brain cancer	0.000901	0.011	CcSEcCtD
Primidone—CHRNA4—telencephalon—brain cancer	0.000897	0.00778	CbGeAlD
Primidone—GRIA2—midbrain—brain cancer	0.000887	0.0077	CbGeAlD
Primidone—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000886	0.0354	CbGpPWpGaD
Primidone—Anaemia—Procarbazine—brain cancer	0.000882	0.0108	CcSEcCtD
Primidone—GABRG2—telencephalon—brain cancer	0.000879	0.00762	CbGeAlD
Primidone—GABRB2—telencephalon—brain cancer	0.000879	0.00762	CbGeAlD
Primidone—GRIK2—medulla oblongata—brain cancer	0.000877	0.00761	CbGeAlD
Primidone—GABRA1—brainstem—brain cancer	0.000874	0.00758	CbGeAlD
Primidone—GRIA2—spinal cord—brain cancer	0.000865	0.00751	CbGeAlD
Primidone—GABRA4—pituitary gland—brain cancer	0.000855	0.00742	CbGeAlD
Primidone—Arthralgia—Procarbazine—brain cancer	0.000812	0.00992	CcSEcCtD
Primidone—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000807	0.0323	CbGpPWpGaD
Primidone—GABRA2—telencephalon—brain cancer	0.000803	0.00696	CbGeAlD
Primidone—GRIK2—midbrain—brain cancer	0.000801	0.00695	CbGeAlD
Primidone—GRIK2—spinal cord—brain cancer	0.000782	0.00678	CbGeAlD
Primidone—Vomiting—Lomustine—brain cancer	0.00078	0.00952	CcSEcCtD
Primidone—GRIA2—endocrine gland—brain cancer	0.000779	0.00676	CbGeAlD
Primidone—GABRA1—telencephalon—brain cancer	0.000776	0.00673	CbGeAlD
Primidone—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00077	0.0308	CbGpPWpGaD
Primidone—GRIA2—head—brain cancer	0.000769	0.00667	CbGeAlD
Primidone—Depression—Carmustine—brain cancer	0.000762	0.0093	CcSEcCtD
Primidone—GABRA6—head—brain cancer	0.000743	0.00645	CbGeAlD
Primidone—Anorexia—Procarbazine—brain cancer	0.000742	0.00906	CcSEcCtD
Primidone—Depression—Temozolomide—brain cancer	0.000736	0.00899	CcSEcCtD
Primidone—Nausea—Lomustine—brain cancer	0.000729	0.00889	CcSEcCtD
Primidone—GABRA5—head—brain cancer	0.000721	0.00625	CbGeAlD
Primidone—GABRG2—pituitary gland—brain cancer	0.000715	0.00621	CbGeAlD
Primidone—CHRFAM7A—endocrine gland—brain cancer	0.00071	0.00616	CbGeAlD
Primidone—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00071	0.00866	CcSEcCtD
Primidone—GRIK2—endocrine gland—brain cancer	0.000704	0.00611	CbGeAlD
Primidone—GRIA2—central nervous system—brain cancer	0.000702	0.00609	CbGeAlD
Primidone—CHRFAM7A—head—brain cancer	0.000701	0.00608	CbGeAlD
Primidone—GRIK2—head—brain cancer	0.000695	0.00603	CbGeAlD
Primidone—Somnolence—Procarbazine—brain cancer	0.000692	0.00845	CcSEcCtD
Primidone—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000691	0.0276	CbGpPWpGaD
Primidone—GABRG2—medulla oblongata—brain cancer	0.00069	0.00599	CbGeAlD
Primidone—GABRB2—medulla oblongata—brain cancer	0.00069	0.00599	CbGeAlD
Primidone—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000687	0.0275	CbGpPWpGaD
Primidone—GRIA2—cerebellum—brain cancer	0.000686	0.00595	CbGeAlD
Primidone—Anaemia—Hydroxyurea—brain cancer	0.000683	0.00833	CcSEcCtD
Primidone—GABRA3—endocrine gland—brain cancer	0.00068	0.0059	CbGeAlD
Primidone—GABRA6—central nervous system—brain cancer	0.000678	0.00589	CbGeAlD
Primidone—Decreased appetite—Procarbazine—brain cancer	0.000677	0.00826	CcSEcCtD
Primidone—Connective tissue disorder—Carmustine—brain cancer	0.000674	0.00823	CcSEcCtD
Primidone—Fatigue—Procarbazine—brain cancer	0.000671	0.0082	CcSEcCtD
Primidone—GABRA3—head—brain cancer	0.000671	0.00582	CbGeAlD
Primidone—GABRA6—cerebellum—brain cancer	0.000663	0.00575	CbGeAlD
Primidone—Visual impairment—Carmustine—brain cancer	0.000661	0.00807	CcSEcCtD
Primidone—GABRA5—central nervous system—brain cancer	0.000658	0.00571	CbGeAlD
Primidone—GABRA4—head—brain cancer	0.000654	0.00567	CbGeAlD
Primidone—Connective tissue disorder—Temozolomide—brain cancer	0.000651	0.00795	CcSEcCtD
Primidone—CHRNA4—midbrain—brain cancer	0.000644	0.00559	CbGeAlD
Primidone—Eye disorder—Carmustine—brain cancer	0.000641	0.00782	CcSEcCtD
Primidone—CHRFAM7A—central nervous system—brain cancer	0.00064	0.00555	CbGeAlD
Primidone—Visual impairment—Temozolomide—brain cancer	0.000639	0.0078	CcSEcCtD
Primidone—GRIK2—central nervous system—brain cancer	0.000634	0.0055	CbGeAlD
Primidone—GABRG2—midbrain—brain cancer	0.000631	0.00547	CbGeAlD
Primidone—GABRB2—midbrain—brain cancer	0.000631	0.00547	CbGeAlD
Primidone—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000628	0.0251	CbGpPWpGaD
Primidone—CHRNA4—spinal cord—brain cancer	0.000628	0.00545	CbGeAlD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000624	0.00762	CcSEcCtD
Primidone—GRIK2—cerebellum—brain cancer	0.00062	0.00538	CbGeAlD
Primidone—Eye disorder—Temozolomide—brain cancer	0.000619	0.00756	CcSEcCtD
Primidone—GABRB2—spinal cord—brain cancer	0.000616	0.00534	CbGeAlD
Primidone—GABRG2—spinal cord—brain cancer	0.000616	0.00534	CbGeAlD
Primidone—GABRA3—central nervous system—brain cancer	0.000613	0.00531	CbGeAlD
Primidone—GABRA1—medulla oblongata—brain cancer	0.000609	0.00529	CbGeAlD
Primidone—Mental disorder—Carmustine—brain cancer	0.000601	0.00733	CcSEcCtD
Primidone—Malnutrition—Carmustine—brain cancer	0.000597	0.00729	CcSEcCtD
Primidone—GABRA4—central nervous system—brain cancer	0.000597	0.00518	CbGeAlD
Primidone—Nervous system disorder—Hydroxyurea—brain cancer	0.000591	0.00721	CcSEcCtD
Primidone—Skin disorder—Hydroxyurea—brain cancer	0.000585	0.00715	CcSEcCtD
Primidone—GABRA4—cerebellum—brain cancer	0.000583	0.00506	CbGeAlD
Primidone—Mental disorder—Temozolomide—brain cancer	0.000581	0.00709	CcSEcCtD
Primidone—Malnutrition—Temozolomide—brain cancer	0.000577	0.00704	CcSEcCtD
Primidone—Anorexia—Hydroxyurea—brain cancer	0.000575	0.00701	CcSEcCtD
Primidone—CHRNA7—endocrine gland—brain cancer	0.000573	0.00497	CbGeAlD
Primidone—CHRNA7—head—brain cancer	0.000566	0.00491	CbGeAlD
Primidone—CHRNA4—endocrine gland—brain cancer	0.000566	0.00491	CbGeAlD
Primidone—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.000564	0.0225	CbGpPWpGaD
Primidone—Phenytoin—CYP2C9—brain cancer	0.00056	0.511	CrCbGaD
Primidone—Asthenia—Procarbazine—brain cancer	0.000559	0.00682	CcSEcCtD
Primidone—CHRNA4—head—brain cancer	0.000558	0.00484	CbGeAlD
Primidone—GRIA2—brain—brain cancer	0.000557	0.00484	CbGeAlD
Primidone—GABRA1—midbrain—brain cancer	0.000557	0.00483	CbGeAlD
Primidone—Anaemia—Carmustine—brain cancer	0.000552	0.00673	CcSEcCtD
Primidone—Agranulocytosis—Etoposide—brain cancer	0.000551	0.00673	CcSEcCtD
Primidone—GABRB2—head—brain cancer	0.000547	0.00475	CbGeAlD
Primidone—GABRG2—head—brain cancer	0.000547	0.00475	CbGeAlD
Primidone—GABRA1—spinal cord—brain cancer	0.000543	0.00472	CbGeAlD
Primidone—GABRA6—brain—brain cancer	0.000538	0.00467	CbGeAlD
Primidone—Phenobarbital—CYP2C9—brain cancer	0.000537	0.49	CrCbGaD
Primidone—Somnolence—Hydroxyurea—brain cancer	0.000536	0.00654	CcSEcCtD
Primidone—Anaemia—Temozolomide—brain cancer	0.000533	0.00651	CcSEcCtD
Primidone—Decreased appetite—Hydroxyurea—brain cancer	0.000524	0.0064	CcSEcCtD
Primidone—GABRA5—brain—brain cancer	0.000522	0.00453	CbGeAlD
Primidone—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00052	0.00635	CcSEcCtD
Primidone—Fatigue—Hydroxyurea—brain cancer	0.00052	0.00634	CcSEcCtD
Primidone—Vertigo—Temozolomide—brain cancer	0.000518	0.00633	CcSEcCtD
Primidone—CHRNA7—central nervous system—brain cancer	0.000517	0.00448	CbGeAlD
Primidone—Dizziness—Procarbazine—brain cancer	0.000515	0.00629	CcSEcCtD
Primidone—CHRNA4—central nervous system—brain cancer	0.00051	0.00442	CbGeAlD
Primidone—CHRFAM7A—brain—brain cancer	0.000508	0.00441	CbGeAlD
Primidone—GRIK2—brain—brain cancer	0.000504	0.00437	CbGeAlD
Primidone—GABRA2—head—brain cancer	0.0005	0.00434	CbGeAlD
Primidone—GABRG2—central nervous system—brain cancer	0.000499	0.00433	CbGeAlD
Primidone—GABRB2—central nervous system—brain cancer	0.000499	0.00433	CbGeAlD
Primidone—CHRNA4—cerebellum—brain cancer	0.000498	0.00432	CbGeAlD
Primidone—Eye disorder—Etoposide—brain cancer	0.000496	0.00605	CcSEcCtD
Primidone—Vomiting—Procarbazine—brain cancer	0.000495	0.00604	CcSEcCtD
Primidone—Arthralgia—Temozolomide—brain cancer	0.000491	0.006	CcSEcCtD
Primidone—Rash—Procarbazine—brain cancer	0.000491	0.00599	CcSEcCtD
Primidone—Dermatitis—Procarbazine—brain cancer	0.000491	0.00599	CcSEcCtD
Primidone—GABRG2—cerebellum—brain cancer	0.000488	0.00423	CbGeAlD
Primidone—GABRB2—cerebellum—brain cancer	0.000488	0.00423	CbGeAlD
Primidone—Headache—Procarbazine—brain cancer	0.000488	0.00595	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000488	0.00595	CcSEcCtD
Primidone—GABRA3—brain—brain cancer	0.000486	0.00422	CbGeAlD
Primidone—GABRA1—head—brain cancer	0.000483	0.00419	CbGeAlD
Primidone—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000477	0.0191	CbGpPWpGaD
Primidone—GABRA4—brain—brain cancer	0.000474	0.00411	CbGeAlD
Primidone—Anorexia—Carmustine—brain cancer	0.000464	0.00567	CcSEcCtD
Primidone—Nausea—Procarbazine—brain cancer	0.000463	0.00565	CcSEcCtD
Primidone—Nervous system disorder—Temozolomide—brain cancer	0.000462	0.00564	CcSEcCtD
Primidone—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000459	0.0183	CbGpPWpGaD
Primidone—Skin disorder—Temozolomide—brain cancer	0.000457	0.00558	CcSEcCtD
Primidone—GABRA2—central nervous system—brain cancer	0.000456	0.00396	CbGeAlD
Primidone—Anorexia—Temozolomide—brain cancer	0.000449	0.00548	CcSEcCtD
Primidone—GABRA2—cerebellum—brain cancer	0.000446	0.00387	CbGeAlD
Primidone—Musculoskeletal discomfort—Carmustine—brain cancer	0.000444	0.00542	CcSEcCtD
Primidone—GABRA1—central nervous system—brain cancer	0.000441	0.00383	CbGeAlD
Primidone—Somnolence—Carmustine—brain cancer	0.000433	0.00529	CcSEcCtD
Primidone—Asthenia—Hydroxyurea—brain cancer	0.000432	0.00528	CcSEcCtD
Primidone—GABRA1—cerebellum—brain cancer	0.000431	0.00374	CbGeAlD
Primidone—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000429	0.00524	CcSEcCtD
Primidone—Anaemia—Etoposide—brain cancer	0.000427	0.00521	CcSEcCtD
Primidone—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000426	0.017	CbGpPWpGaD
Primidone—Decreased appetite—Carmustine—brain cancer	0.000424	0.00517	CcSEcCtD
Primidone—Gastrointestinal disorder—Carmustine—brain cancer	0.000421	0.00513	CcSEcCtD
Primidone—Somnolence—Temozolomide—brain cancer	0.000419	0.00511	CcSEcCtD
Primidone—CYP2C8—pituitary gland—brain cancer	0.000415	0.0036	CbGeAlD
Primidone—Vertigo—Etoposide—brain cancer	0.000415	0.00506	CcSEcCtD
Primidone—CHRNA7—brain—brain cancer	0.00041	0.00356	CbGeAlD
Primidone—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.00041	0.0164	CbGpPWpGaD
Primidone—Decreased appetite—Temozolomide—brain cancer	0.000409	0.005	CcSEcCtD
Primidone—Gastrointestinal disorder—Temozolomide—brain cancer	0.000407	0.00496	CcSEcCtD
Primidone—Fatigue—Temozolomide—brain cancer	0.000406	0.00495	CcSEcCtD
Primidone—CHRNA4—brain—brain cancer	0.000405	0.00351	CbGeAlD
Primidone—Dizziness—Hydroxyurea—brain cancer	0.000399	0.00486	CcSEcCtD
Primidone—GABRG2—brain—brain cancer	0.000396	0.00344	CbGeAlD
Primidone—GABRB2—brain—brain cancer	0.000396	0.00344	CbGeAlD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00039	0.00476	CcSEcCtD
Primidone—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000387	0.0155	CbGpPWpGaD
Primidone—Vomiting—Hydroxyurea—brain cancer	0.000383	0.00468	CcSEcCtD
Primidone—CYP2B6—gonad—brain cancer	0.000382	0.00331	CbGeAlD
Primidone—Rash—Hydroxyurea—brain cancer	0.00038	0.00464	CcSEcCtD
Primidone—Dermatitis—Hydroxyurea—brain cancer	0.00038	0.00463	CcSEcCtD
Primidone—Headache—Hydroxyurea—brain cancer	0.000378	0.00461	CcSEcCtD
Primidone—GABRA6—Orphan transporters—S100A10—brain cancer	0.00037	0.0148	CbGpPWpGaD
Primidone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000369	0.0147	CbGpPWpGaD
Primidone—CYP2C19—endocrine gland—brain cancer	0.000368	0.0032	CbGeAlD
Primidone—Skin disorder—Etoposide—brain cancer	0.000366	0.00447	CcSEcCtD
Primidone—GABRA4—Orphan transporters—S100A10—brain cancer	0.000366	0.0146	CbGpPWpGaD
Primidone—GABRA2—brain—brain cancer	0.000362	0.00314	CbGeAlD
Primidone—Anorexia—Etoposide—brain cancer	0.000359	0.00438	CcSEcCtD
Primidone—Nausea—Hydroxyurea—brain cancer	0.000358	0.00437	CcSEcCtD
Primidone—GABRA1—brain—brain cancer	0.00035	0.00304	CbGeAlD
Primidone—Asthenia—Carmustine—brain cancer	0.00035	0.00427	CcSEcCtD
Primidone—CHRNA7—SIDS Susceptibility Pathways—HES5—brain cancer	0.000345	0.0138	CbGpPWpGaD
Primidone—Asthenia—Temozolomide—brain cancer	0.000338	0.00412	CcSEcCtD
Primidone—Somnolence—Etoposide—brain cancer	0.000335	0.00409	CcSEcCtD
Primidone—GABRB2—Orphan transporters—S100A10—brain cancer	0.000335	0.0134	CbGpPWpGaD
Primidone—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000332	0.0133	CbGpPWpGaD
Primidone—Decreased appetite—Etoposide—brain cancer	0.000328	0.004	CcSEcCtD
Primidone—Gastrointestinal disorder—Etoposide—brain cancer	0.000325	0.00397	CcSEcCtD
Primidone—GABRA5—Orphan transporters—S100A10—brain cancer	0.000325	0.013	CbGpPWpGaD
Primidone—Fatigue—Etoposide—brain cancer	0.000325	0.00396	CcSEcCtD
Primidone—Dizziness—Carmustine—brain cancer	0.000322	0.00393	CcSEcCtD
Primidone—CYP2C8—endocrine gland—brain cancer	0.000322	0.00279	CbGeAlD
Primidone—GRIA2—BDNF signaling pathway—NTRK3—brain cancer	0.000319	0.0128	CbGpPWpGaD
Primidone—GABRA3—Orphan transporters—S100A10—brain cancer	0.000319	0.0128	CbGpPWpGaD
Primidone—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000319	0.0128	CbGpPWpGaD
Primidone—GABRA2—Orphan transporters—S100A10—brain cancer	0.000314	0.0125	CbGpPWpGaD
Primidone—Dizziness—Temozolomide—brain cancer	0.000311	0.0038	CcSEcCtD
Primidone—Vomiting—Carmustine—brain cancer	0.00031	0.00378	CcSEcCtD
Primidone—Rash—Carmustine—brain cancer	0.000307	0.00375	CcSEcCtD
Primidone—Dermatitis—Carmustine—brain cancer	0.000307	0.00375	CcSEcCtD
Primidone—GABRG2—Orphan transporters—S100A10—brain cancer	0.000306	0.0122	CbGpPWpGaD
Primidone—Headache—Carmustine—brain cancer	0.000305	0.00373	CcSEcCtD
Primidone—CYP1A2—endocrine gland—brain cancer	0.000301	0.00261	CbGeAlD
Primidone—Vomiting—Temozolomide—brain cancer	0.000299	0.00365	CcSEcCtD
Primidone—Rash—Temozolomide—brain cancer	0.000297	0.00362	CcSEcCtD
Primidone—Dermatitis—Temozolomide—brain cancer	0.000297	0.00362	CcSEcCtD
Primidone—Headache—Temozolomide—brain cancer	0.000295	0.0036	CcSEcCtD
Primidone—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000292	0.0117	CbGpPWpGaD
Primidone—Nausea—Carmustine—brain cancer	0.000289	0.00353	CcSEcCtD
Primidone—CYP2B6—endocrine gland—brain cancer	0.000288	0.0025	CbGeAlD
Primidone—CYP2C9—endocrine gland—brain cancer	0.000286	0.00248	CbGeAlD
Primidone—CYP2B6—head—brain cancer	0.000285	0.00247	CbGeAlD
Primidone—CHRNA4—SIDS Susceptibility Pathways—HES5—brain cancer	0.000281	0.0112	CbGpPWpGaD
Primidone—Nausea—Temozolomide—brain cancer	0.00028	0.00341	CcSEcCtD
Primidone—Asthenia—Etoposide—brain cancer	0.00027	0.0033	CcSEcCtD
Primidone—GABRA1—Orphan transporters—S100A10—brain cancer	0.000267	0.0107	CbGpPWpGaD
Primidone—CYP2B6—central nervous system—brain cancer	0.00026	0.00226	CbGeAlD
Primidone—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000256	0.0102	CbGpPWpGaD
Primidone—Dizziness—Etoposide—brain cancer	0.000249	0.00304	CcSEcCtD
Primidone—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000246	0.00985	CbGpPWpGaD
Primidone—Vomiting—Etoposide—brain cancer	0.00024	0.00292	CcSEcCtD
Primidone—Rash—Etoposide—brain cancer	0.000238	0.0029	CcSEcCtD
Primidone—Dermatitis—Etoposide—brain cancer	0.000237	0.0029	CcSEcCtD
Primidone—Headache—Etoposide—brain cancer	0.000236	0.00288	CcSEcCtD
Primidone—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000234	0.00936	CbGpPWpGaD
Primidone—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000231	0.00923	CbGpPWpGaD
Primidone—CYP2C8—brain—brain cancer	0.00023	0.002	CbGeAlD
Primidone—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000229	0.00917	CbGpPWpGaD
Primidone—Nausea—Etoposide—brain cancer	0.000224	0.00273	CcSEcCtD
Primidone—CYP3A4—endocrine gland—brain cancer	0.000218	0.00189	CbGeAlD
Primidone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000217	0.00868	CbGpPWpGaD
Primidone—CYP2B6—brain—brain cancer	0.000206	0.00179	CbGeAlD
Primidone—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000205	0.00818	CbGpPWpGaD
Primidone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000198	0.00792	CbGpPWpGaD
Primidone—CYP3A4—central nervous system—brain cancer	0.000196	0.0017	CbGeAlD
Primidone—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000196	0.00782	CbGpPWpGaD
Primidone—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00019	0.00759	CbGpPWpGaD
Primidone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000177	0.00707	CbGpPWpGaD
Primidone—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000176	0.00703	CbGpPWpGaD
Primidone—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000175	0.00698	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—HES5—brain cancer	0.000174	0.00696	CbGpPWpGaD
Primidone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000167	0.0067	CbGpPWpGaD
Primidone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000161	0.00642	CbGpPWpGaD
Primidone—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000159	0.00637	CbGpPWpGaD
Primidone—GRIA2—N-cadherin signaling events—CTNNB1—brain cancer	0.000155	0.00621	CbGpPWpGaD
Primidone—CHRNA7—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000147	0.00587	CbGpPWpGaD
Primidone—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000143	0.00573	CbGpPWpGaD
Primidone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000138	0.00551	CbGpPWpGaD
Primidone—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000136	0.00544	CbGpPWpGaD
Primidone—GABRA6—Ion channel transport—TRPC6—brain cancer	0.00012	0.0048	CbGpPWpGaD
Primidone—CHRNA4—SIDS Susceptibility Pathways—ESR2—brain cancer	0.00012	0.00479	CbGpPWpGaD
Primidone—GABRA4—Ion channel transport—TRPC6—brain cancer	0.000118	0.00474	CbGpPWpGaD
Primidone—CHRNA7—SIDS Susceptibility Pathways—HES1—brain cancer	0.000114	0.00456	CbGpPWpGaD
Primidone—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000112	0.00447	CbGpPWpGaD
Primidone—GABRB2—Ion channel transport—TRPC6—brain cancer	0.000108	0.00433	CbGpPWpGaD
Primidone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000106	0.00425	CbGpPWpGaD
Primidone—GABRA5—Ion channel transport—TRPC6—brain cancer	0.000105	0.00421	CbGpPWpGaD
Primidone—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000105	0.0042	CbGpPWpGaD
Primidone—GABRA3—Ion channel transport—TRPC6—brain cancer	0.000103	0.00413	CbGpPWpGaD
Primidone—GABRA2—Ion channel transport—TRPC6—brain cancer	0.000102	0.00406	CbGpPWpGaD
Primidone—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000101	0.00403	CbGpPWpGaD
Primidone—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	9.94e-05	0.00397	CbGpPWpGaD
Primidone—GABRG2—Ion channel transport—TRPC6—brain cancer	9.91e-05	0.00396	CbGpPWpGaD
Primidone—GRIA2—BDNF signaling pathway—SPP1—brain cancer	9.44e-05	0.00378	CbGpPWpGaD
Primidone—CHRNA4—SIDS Susceptibility Pathways—HES1—brain cancer	9.29e-05	0.00372	CbGpPWpGaD
Primidone—GABRA6—Transmembrane transport of small molecules—S100A10—brain cancer	9.04e-05	0.00362	CbGpPWpGaD
Primidone—CYP3A4—Irinotecan Pathway—APC—brain cancer	9.03e-05	0.00361	CbGpPWpGaD
Primidone—GABRA4—Transmembrane transport of small molecules—S100A10—brain cancer	8.93e-05	0.00357	CbGpPWpGaD
Primidone—GABRA1—Ion channel transport—TRPC6—brain cancer	8.66e-05	0.00346	CbGpPWpGaD
Primidone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	8.62e-05	0.00345	CbGpPWpGaD
Primidone—GRIA2—BDNF signaling pathway—IRS2—brain cancer	8.54e-05	0.00342	CbGpPWpGaD
Primidone—CYP2C8—Biological oxidations—CYP2C9—brain cancer	8.53e-05	0.00341	CbGpPWpGaD
Primidone—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	8.41e-05	0.00336	CbGpPWpGaD
Primidone—GABRB2—Transmembrane transport of small molecules—S100A10—brain cancer	8.17e-05	0.00327	CbGpPWpGaD
Primidone—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	8.01e-05	0.0032	CbGpPWpGaD
Primidone—GABRA5—Transmembrane transport of small molecules—S100A10—brain cancer	7.93e-05	0.00317	CbGpPWpGaD
Primidone—GABRA3—Transmembrane transport of small molecules—S100A10—brain cancer	7.79e-05	0.00312	CbGpPWpGaD
Primidone—GABRA2—Transmembrane transport of small molecules—S100A10—brain cancer	7.66e-05	0.00306	CbGpPWpGaD
Primidone—CYP2C19—Biological oxidations—CYP2C9—brain cancer	7.61e-05	0.00304	CbGpPWpGaD
Primidone—GRIA2—BDNF signaling pathway—APC—brain cancer	7.54e-05	0.00302	CbGpPWpGaD
Primidone—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	7.51e-05	0.003	CbGpPWpGaD
Primidone—GABRG2—Transmembrane transport of small molecules—S100A10—brain cancer	7.47e-05	0.00299	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—ESR2—brain cancer	7.41e-05	0.00296	CbGpPWpGaD
Primidone—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	7.35e-05	0.00294	CbGpPWpGaD
Primidone—GABRA1—Transmembrane transport of small molecules—S100A10—brain cancer	6.53e-05	0.00261	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	6.12e-05	0.00245	CbGpPWpGaD
Primidone—CYP1A2—Biological oxidations—CYP2C9—brain cancer	5.93e-05	0.00237	CbGpPWpGaD
Primidone—GRIA2—BDNF signaling pathway—RELA—brain cancer	5.89e-05	0.00236	CbGpPWpGaD
Primidone—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	5.85e-05	0.00234	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—HES1—brain cancer	5.75e-05	0.0023	CbGpPWpGaD
Primidone—CHRNA7—SIDS Susceptibility Pathways—CTNNB1—brain cancer	5.72e-05	0.00229	CbGpPWpGaD
Primidone—GRIA2—BDNF signaling pathway—CTNNB1—brain cancer	5.12e-05	0.00205	CbGpPWpGaD
Primidone—CHRNA7—SIDS Susceptibility Pathways—VEGFA—brain cancer	5.03e-05	0.00201	CbGpPWpGaD
Primidone—CHRNA4—SIDS Susceptibility Pathways—CTNNB1—brain cancer	4.66e-05	0.00186	CbGpPWpGaD
Primidone—CYP3A4—Biological oxidations—CYP2C9—brain cancer	4.58e-05	0.00183	CbGpPWpGaD
Primidone—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	4.52e-05	0.00181	CbGpPWpGaD
Primidone—GRIA2—BDNF signaling pathway—STAT3—brain cancer	4.47e-05	0.00179	CbGpPWpGaD
Primidone—GABRA6—Transmembrane transport of small molecules—TRPC6—brain cancer	4.18e-05	0.00167	CbGpPWpGaD
Primidone—GABRA4—Transmembrane transport of small molecules—TRPC6—brain cancer	4.12e-05	0.00165	CbGpPWpGaD
Primidone—CHRNA4—SIDS Susceptibility Pathways—VEGFA—brain cancer	4.1e-05	0.00164	CbGpPWpGaD
Primidone—GABRB2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.77e-05	0.00151	CbGpPWpGaD
Primidone—GABRA5—Transmembrane transport of small molecules—TRPC6—brain cancer	3.66e-05	0.00147	CbGpPWpGaD
Primidone—GABRA3—Transmembrane transport of small molecules—TRPC6—brain cancer	3.6e-05	0.00144	CbGpPWpGaD
Primidone—GABRA2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.54e-05	0.00141	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	3.53e-05	0.00141	CbGpPWpGaD
Primidone—GABRG2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.45e-05	0.00138	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.28e-05	0.00131	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	3.18e-05	0.00127	CbGpPWpGaD
Primidone—GABRA1—Transmembrane transport of small molecules—TRPC6—brain cancer	3.02e-05	0.00121	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.92e-05	0.00117	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	2.89e-05	0.00115	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	2.7e-05	0.00108	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—VEGFA—brain cancer	2.54e-05	0.00102	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	2.49e-05	0.000994	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	2.43e-05	0.000972	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	2.43e-05	0.000972	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.4e-05	0.000958	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.28e-05	0.000911	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.14e-05	0.000855	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.95e-05	0.00078	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—CYP2C9—brain cancer	1.72e-05	0.000689	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.67e-05	0.000666	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—BSG—brain cancer	1.47e-05	0.000586	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CYP2C9—brain cancer	1.46e-05	0.000583	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CYP2C9—brain cancer	1.3e-05	0.000521	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—IDH1—brain cancer	1.26e-05	0.000504	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—BSG—brain cancer	1.24e-05	0.000496	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—BSG—brain cancer	1.11e-05	0.000443	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—IDH1—brain cancer	1.07e-05	0.000427	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CYP2C9—brain cancer	1.01e-05	0.000406	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—BSG—brain cancer	1.01e-05	0.000404	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—ENO2—brain cancer	9.96e-06	0.000398	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—IDH1—brain cancer	9.52e-06	0.000381	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.69e-06	0.000347	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—IDH1—brain cancer	8.68e-06	0.000347	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—BSG—brain cancer	8.63e-06	0.000345	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—ENO2—brain cancer	8.43e-06	0.000337	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CYP2C9—brain cancer	7.83e-06	0.000313	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.75e-06	0.00031	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—ENO2—brain cancer	7.53e-06	0.000301	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—IDH1—brain cancer	7.42e-06	0.000297	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.07e-06	0.000283	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—ENO2—brain cancer	6.86e-06	0.000274	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—BSG—brain cancer	6.66e-06	0.000266	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.04e-06	0.000242	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—ENO2—brain cancer	5.86e-06	0.000235	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—IDH1—brain cancer	5.73e-06	0.000229	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PIK3CG—brain cancer	4.57e-06	0.000183	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—ENO2—brain cancer	4.53e-06	0.000181	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PIK3CG—brain cancer	3.87e-06	0.000155	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PIK3CG—brain cancer	3.45e-06	0.000138	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PIK3CG—brain cancer	3.15e-06	0.000126	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PIK3CG—brain cancer	2.69e-06	0.000108	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PIK3CG—brain cancer	2.08e-06	8.3e-05	CbGpPWpGaD
